| scholarly article | Q13442814 |
| P50 | author | Ajay Goel | Q50723416 |
| Alexander Link | Q57088127 | ||
| P2093 | author name string | C Richard Boland | |
| Takeshi Nagasaka | |||
| Juan Jose Lozano | |||
| Francesc Balaguer | |||
| Miriam Cuatrecasas | |||
| P2860 | cites work | miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells | Q21245271 |
| LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription | Q24312958 | ||
| Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 | Q24336747 | ||
| MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma | Q24653676 | ||
| miRecords: an integrated resource for microRNA-target interactions | Q24655642 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs | Q27861053 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy | Q28235397 | ||
| Causes and consequences of microRNA dysregulation in cancer | Q28258994 | ||
| Genetic unmasking of an epigenetically silenced microRNA in human cancer cells | Q28288806 | ||
| The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation | Q28304726 | ||
| Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues | Q33327648 | ||
| MGMT promoter methylation and field defect in sporadic colorectal cancer. | Q34452509 | ||
| Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer | Q34748786 | ||
| MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines | Q34757887 | ||
| Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. | Q34783833 | ||
| Diagnostic and prognostic microRNAs in stage II colon cancer. | Q34803800 | ||
| mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer | Q36103305 | ||
| Epigenetic field for cancerization | Q36774336 | ||
| CpG island hypermethylation of tumor suppressor microRNAs in human cancer | Q36854202 | ||
| Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes | Q39771388 | ||
| Epigenetic regulation of microRNA expression in colorectal cancer | Q39838959 | ||
| DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect | Q39891532 | ||
| Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer | Q39996295 | ||
| Role of miR-143 targeting KRAS in colorectal tumorigenesis. | Q52591361 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | carcinogenesis | Q1637543 |
| P304 | page(s) | 6609-18 | |
| P577 | publication date | 2010-08-15 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis | |
| P478 | volume | 70 |
| Q38605223 | A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients with Ulcerative Colitis-associated Colorectal Cancer. |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q36355868 | A contrasting function for miR-137 in embryonic mammogenesis and adult breast carcinogenesis |
| Q36603339 | A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. |
| Q37536706 | Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence. |
| Q55333901 | Aberrant microRNA-137 promoter methylation is associated with lymph node metastasis and poor clinical outcomes in non-small cell lung cancer. |
| Q27024427 | An update on microRNAs as colorectal cancer biomarkers: where are we and what's next? |
| Q42632659 | Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications. |
| Q42182618 | Association between hMLH1 hypermethylation and JC virus (JCV) infection in human colorectal cancer (CRC). |
| Q48624606 | Association of microRNA137 gene polymorphisms with age at onset and positive symptoms of schizophrenia in a Han Chinese population |
| Q34306332 | Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo |
| Q21245480 | Chemokine receptor CCR6 expression is regulated by miR-518a-5p in colorectal cancer cells |
| Q47833641 | Clinical significance of miRNA host gene promoter methylation in prostate cancer |
| Q46112381 | Colorectal cancer: epigenetic alterations and their clinical implications. |
| Q35269096 | Colorectal cancers with microsatellite instability display unique miRNA profiles. |
| Q36529740 | Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer |
| Q38409303 | Consumption of Red/Processed Meat and Colorectal Carcinoma: Possible Mechanisms Underlying the Significant Association |
| Q90148035 | Correlation between FAK and EGF-Induced EMT in Colorectal Cancer Cells |
| Q34608782 | Curcumin modulates DNA methylation in colorectal cancer cells. |
| Q46181764 | DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies |
| Q38091024 | DNA methylation and cancer development: molecular mechanism |
| Q26998741 | DNA methylation and microRNA dysregulation in cancer |
| Q37962577 | DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family |
| Q37921080 | DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer |
| Q46766407 | Deciphering the epigenetic network in colorectal cancer |
| Q21135494 | Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer |
| Q55459483 | Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR-31. |
| Q39038680 | Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1. |
| Q60048375 | Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives |
| Q34438218 | Dysregulation of microRNAs in colonic field carcinogenesis: implications for screening |
| Q37973293 | Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer |
| Q37830385 | Epigenetic aberrations during oncogenesis. |
| Q36746000 | Epigenetic analysis of microRNA genes in tumors from surgically resected lung cancer patients and association with survival |
| Q41973340 | Epigenetic changes in colorectal cancer |
| Q35974482 | Epigenetic dysregulation in laryngeal squamous cell carcinoma |
| Q22241089 | Epigenetic field defects in progression to cancer |
| Q35898458 | Epigenetic modifications in cardiovascular disease. |
| Q36997510 | Epigenetic regulation of LSD1 during mammary carcinogenesis |
| Q37718295 | Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition. |
| Q38730550 | Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma |
| Q41495056 | Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis. |
| Q41228787 | Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism. |
| Q51770872 | Epigenetics and MicroRNAs in Cancer. |
| Q24598045 | Epigenetics of colorectal cancer |
| Q60923573 | FMSM: a novel computational model for predicting potential miRNA biomarkers for various human diseases |
| Q42719240 | FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells. |
| Q34384632 | Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer |
| Q26862851 | Field cancerisation in colorectal cancer: a new frontier or pastures past? |
| Q38664137 | Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases |
| Q37267318 | Genetics and epigenetics of arrhythmia and heart failure |
| Q86380048 | Genome-wide methylation analysis in vestibular schwannomas shows putative mechanisms of gene expression modulation and global hypomethylation at the HOX gene cluster |
| Q37505070 | Genomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells |
| Q39474898 | Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism |
| Q34050656 | IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer. |
| Q59047795 | Identification of Unique miRNA Biomarkers in Colorectal Adenoma and Carcinoma Using Microarray: Evaluation of Their Putative Role in Disease Progression |
| Q36357667 | Identification of cancer mechanisms through computational systems modeling |
| Q46969516 | Identification of the transcription factor HOXB4 as a novel target of miR-23a. |
| Q30878074 | Identifying cancer-related microRNAs based on gene expression data |
| Q92683639 | Integral analyses of survival-related long non-coding RNA MIR210HG and its prognostic role in colon cancer |
| Q38940594 | Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer |
| Q38940586 | Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer |
| Q39223766 | MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L. |
| Q38020729 | Macro-role of microRNA in gastric cancer |
| Q37698759 | Mecp2-mediated Epigenetic Silencing of miR-137 Contributes to Colorectal Adenoma-Carcinoma Sequence and Tumor Progression via Relieving the Suppression of c-Met |
| Q39140625 | Methylation kinetics and CpG-island methylator phenotype status in colorectal cancer cell lines. |
| Q35981607 | MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation |
| Q38975057 | MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor |
| Q89460802 | MiR-137 suppresses tumor growth and metastasis in clear cell renal cell carcinoma |
| Q34314172 | MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells |
| Q38952716 | MiR-137: an important player in neural development and neoplastic transformation. |
| Q34687078 | MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1. |
| Q38918875 | MiR125a-5p acting as a novel Gab2 suppressor inhibits invasion of glioma |
| Q34497810 | MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators |
| Q89506768 | MiRNA-137-mediated modulation of mitochondrial dynamics regulates human neural stem cell fate |
| Q44542942 | MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer |
| Q37930489 | MicroRNA Dysregulation in Colon Cancer Microenvironment Interactions: The Importance of Small Things in Metastases. |
| Q34538870 | MicroRNA Methylation in Colorectal Cancer |
| Q39361242 | MicroRNA Signatures of Colonic Polyps on Screening and Histology |
| Q37809919 | MicroRNA in colorectal cancer: from benchtop to bedside |
| Q35363689 | MicroRNA library-based functional screening identified miR-137 as a suppresser of gastric cancer cell proliferation |
| Q33763571 | MicroRNA miR-J1-5p as a potential biomarker for JC virus infection in the gastrointestinal tract. |
| Q37869934 | MicroRNA profiling in cancer |
| Q37539416 | MicroRNA-10a is down-regulated by DNA methylation and functions as a tumor suppressor in gastric cancer cells |
| Q35671794 | MicroRNA-137 Contributes to Dampened Tumorigenesis in Human Gastric Cancer by Targeting AKT2. |
| Q38723636 | MicroRNA-137 chemosensitizes colon cancer cells to the chemotherapeutic drug oxaliplatin (OXA) by targeting YBX1. |
| Q42123071 | MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. |
| Q48168117 | MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer. |
| Q43413469 | MicroRNA-137 promoter methylation in oral lichen planus and oral squamous cell carcinoma. |
| Q34309924 | MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism |
| Q37209436 | MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis |
| Q89776452 | MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer |
| Q49624843 | MicroRNA-761 promotes the sensitivity of colorectal cancer cells to 5-Fluorouracil through targeting FOXM1. |
| Q38962311 | MicroRNA-Mediated Reprogramming of Somatic Cells into Neural Stem Cells or Neurons. |
| Q40864983 | MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer |
| Q38550157 | MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer |
| Q37894616 | MicroRNAs in colorectal cancer metastasis. |
| Q38815583 | MicroRNAs regulate KDM5 histone demethylases in breast cancer cells |
| Q52646046 | Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway. |
| Q37416161 | Nano-architectural alterations in mucus layer fecal colonocytes in field carcinogenesis: potential for screening |
| Q42232350 | Nephroblastomas show low expression of microR-204 and high expression of its target, the oncogenic transcription factor MEIS1. |
| Q38174477 | New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs |
| Q37077405 | Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma |
| Q30538395 | Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer |
| Q30454963 | Potential Impact of miR-137 and Its Targets in Schizophrenia |
| Q39227380 | Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer |
| Q42175718 | Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer |
| Q38263343 | Promoter methylated microRNAs: potential therapeutic targets in gastric cancer |
| Q33599015 | Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer |
| Q98287691 | Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy |
| Q37418150 | Regulation of microRNAs by epigenetics and their interplay involved in cancer |
| Q38885469 | Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer |
| Q47211731 | Roles of microRNAs and RNA-Binding Proteins in the Regulation of Colorectal Cancer Stem Cells |
| Q44419905 | SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer |
| Q37997954 | Schizophrenia genetics: putting all the pieces together |
| Q44523176 | Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma |
| Q35070602 | Shielding the messenger (RNA): microRNA-based anticancer therapies |
| Q33908678 | Single-molecule quantification of 5-hydroxymethylcytosine for diagnosis of blood and colon cancers |
| Q48132734 | Small Molecules in Rare Tumors: Emerging Role of MicroRNAs in GIST. |
| Q92074628 | Technological Challenges and Future Issues for the Detection of Circulating MicroRNAs in Patients With Cancer |
| Q28293277 | Temporal microRNA expression during in vitro myogenic progenitor cell proliferation and differentiation: regulation of proliferation by miR-682 |
| Q90224514 | The Differential DNA Hypermethylation Patterns of microRNA-137 and microRNA-342 Locus in Early Colorectal Lesions and Tumours |
| Q37058165 | The RNA-Binding Protein Musashi1: A Major Player in Intestinal Epithelium Renewal and Colon Cancer Development |
| Q30380229 | The Roles of Two miRNAs in Regulating the Immune Response of Sea Cucumber |
| Q52655036 | The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas. |
| Q34441849 | The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer |
| Q91968727 | The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients |
| Q24299112 | The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration |
| Q30883662 | The role of miRNAs in bone metastasis and their significance in the detection of bone metastasis: a review of the published data |
| Q36096641 | The role of microRNAs in colorectal cancer |
| Q37706529 | Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells |
| Q38979078 | Transcriptional targets of the schizophrenia risk gene MIR137. |
| Q35828629 | Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression |
| Q86590458 | [Colorectal cancer screening] |
| Q35897588 | miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation |
| Q92617994 | miR-137 functions as a tumor suppressor gene in pituitary adenoma by targeting AKT2 |
| Q42267634 | miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3. |
| Q39239384 | miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. |
| Q89326345 | miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation |
| Q39609457 | miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. |
| Q48214977 | miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma. |
| Q37581142 | miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells |
| Q46037039 | miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1. |
| Q55016678 | miR-137 suppresses proliferation, migration and invasion of colon cancer cell lines by targeting TCF4. |
| Q38838174 | miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1. |
| Q98182369 | miR-137: A Novel Therapeutic Target for Human Glioma |
| Q39376552 | miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms |
| Q24598174 | miRNA and vascular cell movement |
| Q21135357 | miRNA expression in colon polyps provides evidence for a multihit model of colon cancer |
| Q21133750 | miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer |
| Q43040562 | miRNAs in precancerous lesions of the gastrointestinal tract |
| Q34732990 | microRNA-137 modulates pancreatic cancer cells tumor growth, invasion and sensitivity to chemotherapy |
| Q47128749 | microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer |
| Q39233194 | microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. |
| Q53285686 | microRNAs as novel epigenetic biomarkers for human cancer. |
| Q61626102 | microRNAs in the Malignant Transformation Process |
| Q26865206 | microRNAs: key triggers of neuronal cell fate |
Search more.